Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanling Yishou Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily utilized for its anti-aging, immunomodulatory, and neuroprotective properties. The decoction is a complex mixture typically composed of several tonifying herbs, including *Panax ginseng* (Ren Shen), *Astragalus membranaceus* (Huang Qi), *Polygonum multiflorum* (He Shou Wu), and *Lycium barbarum* (Gou Qi Zi). It is traditionally indicated for symptoms associated with "Kidney deficiency" and general debility in the elderly. Pharmacological research indicates that the formula works by enhancing antioxidant enzyme activity, such as superoxide dismutase (SOD), and reducing lipid peroxidation markers like malondialdehyde (MDA). Clinical studies in China have explored its efficacy in improving cognitive function, managing mild cognitive impairment, and supporting overall vitality in aging populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanling Yishou Decoction.